Lv7
4839 积分 2021-07-15 加入
Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development
4天前
已完结
Immunogenicity Assays Used in Support of Marketing Applications of Oligonucleotide Therapeutics
4天前
已完结
Scientific perspectives on in vivo developmental neurotoxicity testing: study design, regulatory context, and future directions
4天前
已完结
Integrating New Approach Methodologies and Artificial Intelligence to Advance Central Nervous System Toxicity Prediction: Lessons from Preclinical and Clinical Case Studies
6天前
已完结
Vaccine Ligand Binding Assay Development
6天前
已完结
Four Decades of History & Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)—Part II: Dose Individualization and Approvability Evidence
6天前
已完结
Four decades of History & Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)– Part I: Product Quality
6天前
已完结
Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs
29天前
已完结
Novel Antiplatelet Agents: ALX-0081, a Nanobody Directed towards von Willebrand Factor
29天前
已完结
Integrating New Approach Methodologies and Artificial Intelligence to Advance Central Nervous System Toxicity Prediction: Lessons from Preclinical and Clinical Case Studies
29天前
已完结
皖公网安备34019202002308
